Cizzle And Bio-Techne Completes Evaluation Programme For Detection Of CIZ1B Using ProteinSimple Branded Simple Western Platform
Portfolio Pulse from Benzinga Newsdesk
Cizzle and Bio-Techne have completed an evaluation program for the detection of CIZ1B using ProteinSimple's Simple Western platform. The program aimed to develop a reliable method for detecting CIZ1B, a potential biomarker for lung cancer.
September 19, 2023 | 6:14 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bio-Techne's partnership with Cizzle on the evaluation program could potentially enhance its product offerings and reputation in the biotech industry.
The successful completion of the evaluation program could potentially lead to the development of a new product or service for Bio-Techne. This could enhance the company's product portfolio and reputation in the biotech industry, potentially leading to increased sales and revenue.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100